{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:16:56Z","timestamp":1782544616737,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.jinf.2011.10.014","type":"journal-article","created":{"date-parts":[[2011,11,5]],"date-time":"2011-11-05T18:26:45Z","timestamp":1320517605000},"page":"76-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis"],"prefix":"10.1016","volume":"64","author":[{"given":"Conrad K.","family":"Muzoora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taseera","family":"Kabanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Ortu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ssentamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasco","family":"Hearn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mwesigye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph N.","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2011.10.014_bib1","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/QAD.0b013e3282a4a64d","article-title":"HIV-associated cryptococcal meningitis","volume":"21","author":"Jarvis","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2011.10.014_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2011.10.014_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out","volume":"23","author":"Jarvis","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.jinf.2011.10.014_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical Practice guidelines for the management of cryptococcal disease: 2010 update by the infectious disease society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib5","first-page":"25","article-title":"Guidelines for the prevention, diagnosis and management of cryptococcal meningitis and disseminated cryptococcosis in HIV-infected patients","year":"2007","journal-title":"Southern Afr J HIV Med"},{"key":"10.1016\/j.jinf.2011.10.014_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1473-3099(05)70197-3","article-title":"Antiretroviral rollout, antifungal roll-back: access to treatment for cryptococcal meningitis","volume":"5","author":"Bicanic","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2334-6-118","article-title":"Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg\/day or 400 mg\/day of fluconazole","volume":"6","author":"Schaars","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib9","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib10","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1086\/507895","article-title":"Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution","volume":"43","author":"Bicanic","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high dose fluconazole is superior to fluconazole monotherapy for cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib13","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/599112","article-title":"A Phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-Associated cryptococcal meningitis","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV: a randomized study","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib15","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2011.10.014_bib16","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptocccal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2011.10.014_bib17","doi-asserted-by":"crossref","first-page":"e8630","DOI":"10.1371\/journal.pone.0008630","article-title":"Treatment of cryptococcal meningitis in KwaZulu-Natal, South Africa","volume":"5","author":"Lightowler","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2011.10.014_bib18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.7326\/0003-4819-113-3-183","article-title":"Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial","volume":"113","author":"Larsen","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2011.10.014_bib19","first-page":"1677","article-title":"Comparison of one week with two week regimens of amphotericin B both followed by fluconazole in the treatment of cryptococcal meningitis among AIDS patients","volume":"89","author":"Tansuphaswadikul","year":"2006","journal-title":"J Med Assoc Thai"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445311005330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:16:03Z","timestamp":1759007763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445311005330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0163445311005330"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2011.10.014","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2011.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}